We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia (COVID-19EXO2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04602442
Recruitment Status : Unknown
Verified October 2020 by Olga Tyumina, State-Financed Health Facility "Samara Regional Medical Center Dinasty".
Recruitment status was:  Enrolling by invitation
First Posted : October 26, 2020
Last Update Posted : October 26, 2020
Clinics of the Federal State Budgetary Educational Institution SSMU
Samara Regional Clinical Hospital V.D. Seredavin
Information provided by (Responsible Party):
Olga Tyumina, State-Financed Health Facility "Samara Regional Medical Center Dinasty"

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : December 30, 2021